Although RB1 and P53 protein expression might have clinical importance in surgically treated NSCLC patients [5], the biallelic losses of RB1 and TP53 (the genomic hallmark of SCLC) are so prevalent in SCLC that they cannot define subclasses [1, 6, 7]. Here, TP53 is linked to small cell lung carcinoma.